Hepion Pharmaceuticals, Inc. (HEPA) Insider Trading

Name: Hepion Pharmaceuticals, Inc. (HEPA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Danina Fisher (Director): Purchase of 200,000 shares, $10.0K.

Get alerted when insiders trade HEPA

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta